EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Approval to Initiate Randomized Clinical Trial Evaluating Focal One® as a Potential Treatment for Rectal Deep Infiltrating Endometriosis
November 30, 2022 16:01 ET | EDAP TMS S.A.
  Study to begin enrolling patients in Q2 2023   Endometriosis represents significant expansion opportunity for Focal One  LYON, France, November 30, 2022 -- EDAP TMS SA (Nasdaq: EDAP)...
Atos déploie avec su
Atos déploie avec succès Mon Espace Santé
November 23, 2022 04:10 ET | Atos International
Atos déploie avec succèsMon Espace Santé Mon Espace Santé permet à 65 millions d’assurés d’accéder à des services numériques de santé dans un cadre souverain et sécurisé Paris, France – le 23...
Atos successfully de
Atos successfully deploys Mon Espace Santé, France’s online health platform
November 23, 2022 04:10 ET | Atos International
Atos successfully deploysMon Espace Santé, France’s online health platform Mon Espace Santé enables 65 million people to access digital health services in a sovereign and secure environment Paris,...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP to Present at the Piper Sandler 34th Annual Healthcare Conference
November 21, 2022 08:00 ET | EDAP TMS S.A.
LYON, France, November 21, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (the “Company”), a global leader in robotic energy-based therapies, announced today that Marc Oczachowski, Chief Executive Officer, is...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Reports Third Quarter 2022 Results
November 16, 2022 16:35 ET | EDAP TMS S.A.
Generated Q3 2022 total revenue of approximately EUR 12.2 million (USD 12.3 million), an increase of 29.7 % as compared to EUR 9.4 million (USD 11.1 million) for Q3 2021; nine-month year-to-date...
Post_NewLogo.png
Qlik Cloud Enables U.S. Healthcare Organizations to Leverage Cloud Data for Improved Patient Outcomes
November 15, 2022 08:30 ET | Qlik Technologies, Inc.
PHILADELPHIA, Nov. 15, 2022 (GLOBE NEWSWIRE) -- Qlik® recently enabled Qlik Cloud® with enhanced encryption to securely host personal health information (PHI) subject to U.S. HIPAA requirements...
Ekosi Health Partner
Ekosi Health Partners with Cerebra to Evaluate Effectiveness of Clinical Cannabinoid Therapy on Sleep Quality
November 08, 2022 07:00 ET | Ekosi Health
Gimli, Manitoba, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Ekosi Health, a Canadian-based and Indigenous-owned healthcare provider specializing in clinical cannabinoid therapy, announces its partnership...
Truveta Studio COVID-19 dashboard
Truveta Studio delivers the health data and analytics the world deserves now
November 02, 2022 09:00 ET | Truveta
BELLEVUE, Wash., Nov. 02, 2022 (GLOBE NEWSWIRE) -- Today, Truveta announced the availability of Truveta Studio, bringing together unprecedented health data and analytics for researchers to study...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP TMS SA to Announce Third Quarter 2022 Financial Results on Wednesday, November 16th, 2022
November 02, 2022 08:00 ET | EDAP TMS S.A.
Company to host conference call and webcast on Thursday, November 17th at 8:30 am EDT LYON, France, November 2, 2022 - EDAP TMS SA (Nasdaq: EDAP), the global leader in robotic energy-based therapies,...
EDAP-TMS_RGB-300dpi-20160111.png
EDAP Announces Focal One® HIFU Reimbursement Raised to Urology APC Level 6 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY23
November 01, 2022 17:22 ET | EDAP TMS S.A.
Final rule significantly raises Medicare reimbursement to U.S. hospitals performing a Focal One HIFU prostate ablation procedure LYON, France, November 1, 2022 -- EDAP TMS SA (Nasdaq: EDAP) (“the...